Bank of America’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3
Closed -$7 6640
2025
Q4
$7 Buy
3
+1
+50% +$4 ﹤0.01% 7217
2025
Q3
$11 Sell
2
-27
-93% -$206 ﹤0.01% 8217
2025
Q2
$218 Buy
29
+3
+12% +$22 ﹤0.01% 7830
2025
Q1
$171 Buy
26
+1
+4% +$12 ﹤0.01% 7726
2024
Q4
$329 Hold
25
﹤0.01% 7486
2024
Q3
$142 Sell
25
-6,459
-100% -$42.9K ﹤0.01% 7645
2024
Q2
$38.1K Buy
6,484
+5,815
+869% +$52K ﹤0.01% 6585
2024
Q1
$6.04K Sell
669
-2,345
-78% -$28K ﹤0.01% 6972
2023
Q4
$33.1K Buy
3,014
+1,690
+128% +$18.8K ﹤0.01% 6691
2023
Q3
$23.4K Buy
1,324
+289
+28% +$10.5K ﹤0.01% 6682
2023
Q2
$56.8K Buy
1,035
+178
+21% +$11.3K ﹤0.01% 6413
2023
Q1
$58.3K Sell
857
-1,268
-60% -$98.6K ﹤0.01% 6451
2022
Q4
$129K Buy
2,125
+842
+66% +$78.3K ﹤0.01% 6137
2022
Q3
$128K Buy
1,283
+472
+58% +$55K ﹤0.01% 6219
2022
Q2
$72K Buy
811
+92
+13% +$11.2K ﹤0.01% 6651
2022
Q1
$108K Buy
719
+688
+2,219% +$128K ﹤0.01% 6825
2021
Q4
$10K Sell
31
-130
-81% -$45.8K ﹤0.01% 7698
2021
Q3
$72K Buy
+161
New +$51K ﹤0.01% 6882

Other funds holding RBOT

Bank of America's RBOT Position: Q1 2026 in Review

Bank of America sold out of Vicarious Surgical (RBOT) in Q1 2026, closing a stake of 3 shares — an estimated $7 sold.

Bank of America first reported a position in RBOT in Q3 2021 and held it in 18 quarters. The position peaked at $129K in Q4 2022. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • Bank of America reported no remaining Vicarious Surgical position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 3 Vicarious Surgical shares in Q1 2026, an estimated $7.
  • Bank of America first reported a position in Vicarious Surgical in Q3 2021 and held it in 18 quarters.
  • Bank of America's Vicarious Surgical position peaked at $129K in Q4 2022.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.